Graham Doyle

Stock Analyst at UBS

(2.11)
# 2,932
Out of 4,975 analysts
11
Total ratings
60%
Success rate
5.66%
Average return

Stocks Rated by Graham Doyle

Fresenius Medical Care AG
Sep 2, 2025
Downgrades: Sell
Price Target: n/a
Current: $24.77
Upside: -
GE HealthCare Technologies
May 5, 2025
Upgrades: Neutral
Price Target: $74$73
Current: $75.73
Upside: -3.60%
Smith & Nephew
Mar 12, 2025
Downgrades: Neutral
Price Target: n/a
Current: $38.09
Upside: -
Koninklijke Philips
Feb 20, 2025
Upgrades: Buy
Price Target: n/a
Current: $27.93
Upside: -